Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in α1-antitrypsin deficiency: The Copenhagen City Heart Study

Circulation

Volumn 107, Issue 5, 2003, Pages 747-752

  Dahl, Morten ^a   Tybjærg Hansen, Anne ^b,d   Sillesen, Henrik ^a   Jensen, Gorm ^d   Steffensen, Rolf ^c   Nordestgaard, Børge G ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Blood pressure; Genetics; Heart diseases; Ischemia; Stroke

Indexed keywords

ADULT; AGE; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DENMARK; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN DEFICIENCY; BLOOD PRESSURE; BRAIN ISCHEMIA; COMORBIDITY; DENMARK; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK ASSESSMENT;

EID: 0037432148     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000049642.20484.5D     Document Type: Article

References (28)

1. 1-Antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2000:5559-5584.
2. Kato T, Kitámura H, Kanisawa M. Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertension. Exp Mol Pathol. 1989; 50:303-315.
3. Ooyama T, Sakamato H. Elastase in the prevention of arterial ageing and the treatment of atherosclerosis. In: The Molecular Biology and Pathology of Elastic Tissues. Ciba Found Symposium. 1995;192: 307-320.
4. Zureik M, Robert L, Courbon D, et al. Serum elastase activity, serum elastase inhibitors, and occurrence of carotid atherosclerotic plaques: the etude sur le vieillissement artériel (EVA) study. Circulation. 2002;105: 2638-2645.
5. 1-antitrypsin phenotypes. Chest. 1991;100:703-708.
6. Schnohr P, Jensen G, Lange P, et al. The Copenhagen City Heart Study: Østerbroundersøgelsen. Tables with data from the third examination 1991-1994. Eur Heart J Suppl. 2001;3(H):H1-H83.
7. Agerholm-Larsen, Tybjærg-Hansen A, Frikke-Schmidt R, et al. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med. 1997;127:346-355.
8. Sethi A, Tybjærg-Hansen A, Groønholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Ann Intern Med. 2001; 134:941-954.
9. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation. 2000;101:1907-1912.
10. 1-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem. 2001;47:56-62.
11. 1-Antitrypsin: a guardian of vascular tissue. Mayo Clin Proc. 1994;69:1123-1124.
12. Forsyth KD, Talbot V, Beckman I. Endothelial serpins: protectors of the vasculature? Clin Exp Immunol. 1994;95:277-282.
13. Smith EB. Molecular interactions in human atherosclerotic plaques. Am J Pathol. 1977;86:665-674.
14. Hollander W, Colombo MA, Kirkpatrick B, et al. Soluble proteins in the human atherosclerotic plaque: with spectral reference to immunoglobins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis. 1979;34:391-405.
15. Boomsma DI, Orbeleke JF, Martin NG, et al. Alpha-1-antitrypsin and blood pressure. Lancet. 1991;337:1547.
16. Ahlgren AR, Piitulainen E, Sonesson B, et al. Changes in aortic wall stiffness in men with alpha 1-antitrypsin deficiency. Eur J Vasc Endovasc Surg. 1997;14:252-257.
17. 1-antitrypsin deficiency alleles and blood pressure in an Australian population. Clin Exp Pharm Physiol. 1996;23:600-601.
18. Eriksson EE, Xie X, Werr J, et al. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 2001;15:1149-1157.
19. Augier T, Charpiot P, Chareyre C, et al. Medial elastic structure alterations in atherosclerotic arteries in minipigs: plaque proximity and arterial site specificity. Matrix Biol. 1997;15:455-467.
20. 1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. Mol Cell Biol Res Commun. 2000;4:50-61.
21. 1-antiproteinase inhibitor: further evidence for methionine at the reactive center. J Biol Chem. 1979;254:4022-4026.
22. 1-antitrypsin heterozygotes (Pi type MZ). Am Rev Respir Dis. 1974; 110: 709-715.
23. 1-antitrypsin deficiency (Pi MZ) on lung function. Eur J Respir Dis. 1985;67:279-285.
24. 1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med. 2002;136:270-279.
25. Elzouki AN, Ahlgren AR, Länne T, et al. Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur J Vasc Endovasc Surg. 1999;17:149-154.
26. Katsunuma H, Shimizu K, Ebihara T, et al. Anti-atherosclerotic action of elastase: with special reference to its effect on elastic fibres. Age Ageing 1983; 12:183-194.
27. Pierce JA, Eradio B, Dew TA. Antitrypsin phenotypes in St. Louis. JAMA. 1975;238:609-612.
28. 1-Antitrypsin, emphysema and smoking. N Z Med J. 1984; 97:327-328.